Company Overview
Snapshot
Founded in July 2020 by Michal Mark Danieli, EARLY Labs operates with 1–10 employees. The company has raised $4 million across one funding round from one investor. In February 2023, the company gained significant media attention for its innovative approach to cancer detection.
Business overview
EARLY Labs is a Bio-Tech company specializing in Volatile Organic Compound-based diagnostics within the Health Tech & Life Sciences sector. The company is developing a multi-cancer test platform, currently focused on lung cancer, that detects the disease in urine samples with high sensitivity and specificity. This technology aims to simplify cancer screening, making it accessible for at-home or pharmacy use, thereby addressing existing barriers like invasiveness and inconvenience in the healthcare market.
Strategic signal
In early 2023, EARLY Labs garnered considerable media attention across multiple publications for its pioneering work in training rats to detect lung cancer by sniffing urine samples. This innovative approach, which reportedly achieves high accuracy, signals a potential paradigm shift in early cancer detection methods, offering a non-invasive and accessible screening solution that could significantly impact patient outcomes and healthcare delivery.
Log in to access full profile ›Company Intelligence Q&A
- What is EARLY Labs' primary focus in diagnostics?
- EARLY Labs is primarily focused on developing a multi-cancer test platform using Volatile Organic Compound-based diagnostics, with an initial emphasis on detecting lung cancer from urine samples.
- Who founded EARLY Labs?
- EARLY Labs was founded by Michal Mark Danieli, who also serves as the CEO.
- When was EARLY Labs founded?
- EARLY Labs was founded in July 2020.
- What is the reported accuracy of EARLY Labs' lung cancer detection method?
- EARLY Labs' platform for lung cancer detection in urine samples has shown a groundbreaking 90% stage I sensitivity and specificity results.
- What is the total disclosed capital raised by EARLY Labs?
- EARLY Labs has raised a total of $4 million across one funding round.